Stay updated on Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry, v3.7.0, is added to the record history and the prior revision, v3.6.6, is removed, signaling an update to the study record’s documentation. This reflects an updated version of the study record rather than changes to participant data or study results.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe record history was updated to add a new revision entry v3.6.6 and remove the previous revision v3.6.5, reflecting a change to the page's version history.SummaryDifference0.1%

- Check45 days agoChange DetectedA new 'Study Status' entry is added to the record history, indicating that the current status is now tracked in the revision log. The revision history now shows a total of 24 entries for this study, reflecting the expanded history and recent update.SummaryDifference0.3%

- Check52 days agoChange DetectedThe record history now lists the latest version as v3.6.5, replacing v3.6.4. This indicates a minor system revision to the study history page.SummaryDifference0.1%

- Check67 days agoChange DetectedA new revision entry, v3.6.4, was added to the page history and the previous revision, v3.6.3, was removed, indicating a minor update to the record's revision history rather than substantive changes to the study.SummaryDifference0.1%

- Check74 days agoChange DetectedNew version 23 (submitted 2026-07-14) adds a Study Status update to the record, with the latest update posted on 2026-07-15. The entry dated 2026-02-17 was removed from the history.SummaryDifference0.3%

Stay in the know with updates to Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.